Parvimonas micra as a causative organism of spondylodiscitis: a report of two cases and a literature review  by Uemura, Haruka et al.
International Journal of Infectious Diseases 23 (2014) 53–55Case Report
Parvimonas micra as a causative organism of spondylodiscitis:
a report of two cases and a literature review
Haruka Uemura a,*, Kayoko Hayakawa a, Kayo Shimada b, Masayoshi Tojo a,b,
Maki Nagamatsu a,b, Tohru Miyoshi-Akiyama b, Saeko Tamura c, Kazuhisa Mesaki c,
Kei Yamamoto a, Yasuaki Yanagawa a, Jun Sugihara a, Satoshi Kutsuna a,
Nozomi Takeshita a, Naoki Shoda d, Akiyoshi Hagiwara e, Teruo Kirikae b, Norio Ohmagari a
aDisease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan
bDepartment of Infectious Diseases, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan
cDepartment of Clinical Laboratory, National Center for Global Health and Medicine, Tokyo, Japan
dDepartment of Orthopedic Surgery, National Center for Global Health and Medicine, Tokyo, Japan
eDepartment of Emergency Medicine and Critical Care, National Center for Global Health and Medicine, Tokyo, Japan
A R T I C L E I N F O
Article history:
Received 7 December 2013
Received in revised form 2 February 2014
Accepted 5 February 2014
Corresponding Editor: Eskild Petersen,
Aarhus, Denmark
Keywords:
16S rRNA gene sequencing
Anaerobic bacteria
Parvimonas micra
Peptostreptococcus micros
Spondylodiscitis
S U M M A R Y
Spondylodiscitis caused by Parvimonas micra, a rarely reported infection, might be under-detected using
conventional methods. This report of the detection and treatment of two cases of spondylodiscitis due to
P. micra and review of the literature indicates that the use of gene sequencing methods might improve the
accuracy of diagnosing this infection.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-
sa/3.0/).
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The Parvimonas genus has undergone recent reclassiﬁcation.
Originally classiﬁed as Peptostreptococcus micros, the Gram-
positive anaerobic cocci (GPAC) currently classiﬁed as Parvimonas
micra were ﬁrst reclassiﬁed as Micromonas micros in 1999 before
being reclassiﬁed as P. micra in 2006.1 Known as an oral pathogen,
P. micra is a constituent of the normal ﬂora of the human oral cavity
and gastrointestinal tract.2 Although P. micra has been implicated
in infections outside the oral cavity,2 to our knowledge, few cases
of P. micra spondylodiscitis have been reported.3 Here we describe
the diagnosis and successful treatment of two cases of spondy-
lodiscitis caused by P. micra after detection using a relatively novel
method, and compare these two cases with those described
previously.* Corresponding author. Tel.: +81 3 3202 7181; fax: +81 3 207 1038.
E-mail address: ueueuemura@yahoo.co.jp (H. Uemura).
http://dx.doi.org/10.1016/j.ijid.2014.02.007
1201-9712/ 2014 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-sa/3.0/).2. Methods
A search of the PubMed database for journal articles written in
English, using the search terms ‘spondylodiscitis’, ‘osteomyelitis’,
‘vertebra’, ‘discitis’, ‘Peptostreptococcus’, ‘Micromonas’, ‘Parvimo-
nas’, and ‘anaerobic’, was carried out. The search revealed only ﬁve
cases of spondylodiscitis caused by GPAC reported since 1980,
including two cases of P. micra (under its former classiﬁcation
Peptostreptococcus micros), one case of Peptoniphilus asaccharolyticus,
one case of Finegoldia magna, and one undetected case.3 A brief
summary of the two cases of spondylodiscitis due toP. micra reported
previously (cases 1 and 2) and our two cases (cases 3 and 4) is given
below; a clinical summary of these four cases is given in Table 1.
3. Case reports
3.1. Case 13
A 70-year-old male was admitted to hospital with lower back
pain. A computed tomography (CT) scan revealed destructiveciety for Infectious Diseases. This is an open access article under the CC BY-NC-SA
Table 1
Clinical summary of cases with spondylodiscitis due to Parvimonas micraa
Case Age,
years
Sex Clinical features Past medical
history
Site Sample Method of
pathogen
detection
Treatment Outcome
Case 13 70 M Lower back pain,
weight loss, fever
Cataract operations,
transurethral resection
of the prostate, inguinal
herniorrhaphy
L4–L5 Needle biopsy
of paravertebral
mass
Isolation
by culture
(RapID-ANA)
Clindamycin IV 6 weeks No relapse
Case 23 70 M Lower back pain Ulcerative colitis,
benign prostatic
hypertrophy
L5–S1 CSF sample via
cysternal tap
Isolation by
culture
(RapID-ANA II)
Penicillin IV 4 weeks and
oral amoxicillin 4 weeks
in addition to metronidazole
(2 weeks IV and 6 weeks oral)
No relapse
Case 3 84 M Lower back pain Benign prostatic
hypertrophy,
periodontitis
L3–L4 Surgical bone
sampling
16S rRNA Ampicillin–sulbactam
IV 8 weeks and oral
amoxicillin–clavulanate
4 weeks
No relapse
Case 4 85 F Malaise, anorexia Hypertension, periodontitis Th9– Th10 Blood culture Isolation by
culture
(Rapid ID 32A)
Doripenem IV 12 days and
ampicillin IV 4 weeks and
oral amoxicillin 8 weeks
No relapse
M, male; F, female; IV, intravenous; CSF, cerebrospinal ﬂuid.
a Reported as Peptostreptococcus micros in reference3.
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identiﬁed by RapID-ANA system and Gram stain.
3.2. Case 23
A 70-year-old male was admitted to hospital with lower back
pain. Magnetic resonance imaging (MRI) showed spondylodiscitis
(L5–S1). GPAC were isolated from broth media culture of spinal
ﬂuid and were identiﬁed as P. micra by RapID-ANA II system.
3.3. Case 3
An 83-year-old Japanese male was admitted to our hospital for
the treatment of lower back pain of 6-week duration. The patient
presented with a history of benign prostate hypertrophy,
temperature of 37.0 8C, tenderness over L3, and periodontitis.
He had been taking oral levoﬂoxacin for 5 days prior to admission.
The neurological examination was normal, white blood cell count
(WBC) was 9.18  109/l, and erythrocyte sedimentation rate (ESR)
was 34 mm/h. After CT scan and MRI conﬁrmed the suspected L3–
L4 spondylodiscitis, a needle biopsy of the lumbar spine was
performed and specimens were sent for aerobic, anaerobic, and
mycobacterial cultures.
After observation of negative bacterial culture for 1 week,
surgical biopsy of the vertebral bones was performed. Although
Gram staining showed Gram-negative rods (GNRs), the culture of
vertebral bone was negative. In response to this discrepancy, 16S
rRNA gene sequencing (16S rRNA) was performed and P. micra was
detected. The patient was treated successfully with the adminis-
tration of 3 g ampicillin–sulbactam every 6 h for 8 weeks, followed
by 4 weeks of administration of 625 mg oral amoxicillin–
clavulanate every 8 h. MRI conducted 10 months after treatment
revealed no recurrence of spondylodiscitis.
3.4. Case 4
An 85-year-old Japanese female was admitted to the hospital
for treatment of worsening malaise and anorexia of 1-month
duration. The patient presented with a history of hypertension,
temperature of 37.1 8C, and periodontitis. The neurological
examination was normal, WBC was 28.46  109/l, and platelet
count was 91  109/l. CT scan and MRI conﬁrmed Th9–Th10
spondylodiscitis and paravertebral abscess. After collection of
blood culture, empiric doripenem was initiated. After the blood
culture became positive for P. micra and Fusobacterium nucleatusand following a review of susceptibility test results, antibiotic
treatment was de-escalated to 3 g of ampicillin every 6 h. The
patient was successfully treated with intravenous ampicillin for 4
weeks, followed by 8 weeks of oral amoxicillin 500 mg every 6 h.
4. Discussion
The major pathogen in spondylodiscitis is Staphylococcus
aureus, followed by GNRs, coagulase-negative staphylococci, and
streptococci; reports of anaerobic bacteria are relatively rare. An
article reported that the causative pathogen of spondylodiscitis
was an anaerobic bacterium in less than 4% of cases,4 and
spondylodiscitis caused by GPAC has rarely been reported.
P. micra as a pathogen in spondylodiscitis might be under-
estimated due to the difﬁculty of culturing this anaerobic
organism.3 In case 3, the diagnosis of spondylodiscitis caused by
P. micra was possible only by 16S rRNA, and culture was negative
for P. micra. The reason for the negative culture results might have
been previous exposure to antibiotics and/or inappropriate
handling of the specimen. 16S rRNA has recently played an
important role in the accurate identiﬁcation of bacterial isolates
and the discovery of novel bacteria in clinical settings when the
conventional culture method has failed to identify the pathogen.5 A
high clinical suspicion and careful identiﬁcation of anaerobic
bacteria, in addition to molecular diagnostic techniques, appear to
be the key factors for the identiﬁcation of P. micra. In addition, the
collection of vertebral body specimens might improve the accuracy
of diagnosis of spondylodiscitis caused by P. micra, as shown in the
cases presented in this report.3
In the current report, cases 3 and 4 presented with periodontitis
and cases 1–3 presented with an underlying prostate-related
condition. As P. micra is a constituent of the normal oral ﬂora and
genital tract,2 it is reasonable to assume that these conditions
predisposed the patients to spondylodiscitis caused by P. micra. All
four cases described here were in elderly persons (mean age 77.3
years, range 70–85 years), suggesting that old age could be a major
risk factor for spondylodiscitis due to P. micra.
The GNRs observed with Gram staining in case 3 were not
observed by culture or 16S rRNA. It is unlikely that such a
discrepancy was due to the greater precision of Gram staining, as
all the processes were repeated at least twice by experienced
microbiology technicians. Rather, it is probably due to inappropri-
ate handling of the specimen or culture conditions, especially if the
pathogens were extremely fastidious. While the reason why 16S
rRNA failed to identify GNR remains unclear, we hypothesize that it
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insufﬁciency of the database used to conduct the 16S rRNA. As
such, failure of identiﬁcation could have led to misdiagnosis of this
condition (i.e., culture-negative spondylodiscitis); further research
into the reasons is warranted.
Penicillins, metronidazole, and clindamycin are generally
considered the antibiotics of choice for P. micra. In case 1 and case
4, clindamycin and ampicillin were selected, respectively, based on
susceptibility results.3 In case 2, metronidazole was added for better
penetration into the central nervous system.3 In case 3, based on the
consideration of possible resistance because P. micra had been
identiﬁed only by 16S rRNA, ampicillin–sulbactam was adminis-
tered to ensure sufﬁcient coverage of P. micra and possible anaerobic
GNRs. Resistance to penicillin, metronidazole, and clindamycin in
the treatment of spondylodiscitis caused by P. micra has been
reported in several cases.2 Although antibiotic resistance in P. micra
is not yet a signiﬁcant issue, obtaining culture results to identify
susceptibility is important for the determination of appropriate
antimicrobial therapy. The optimal duration of therapy is unknown.In the four cases described here, the total duration of successful
therapy ranged from 6 to 12 weeks without relapse.
In summary, the results of the two spondylodiscitis cases
caused by P. micra described here strongly indicate that 16S rRNA
is a useful method for detecting sensitive pathogens in the
diagnosis of spondylodiscitis caused by P. micra.
Conﬂict of interest: No conﬂict of interest to declare.
References
1. Tindall BJ, Euzeby JP. Proposal of Parvimonas gen. nov. and Quatrionicoccus gen.
nov. as replacements for the illegitimate, prokaryotic, generic names Micro-
monas Murdoch and Shah 2000 and Quadricoccus Maszenan et al., 2002,
respectively. Int J Syst Evol Microbiol 2006;56:2711–3.
2. Murdoch DA. Gram-positive anaerobic cocci. Clin Microbiol Rev 1998;11:81–120.
3. Fraisse T, Lavigne JP, Lechiche C, Leroux JL, Sotto A. Spondylodiscitis due to
Peptostreptococcus spp: a case report. Joint Bone Spine 2009;76:104–5.
4. Gouliouris T, Aliyu SH, Brown NM. Spondylodiscitis: update on diagnosis and
management. J Antimicrob Chemother 2010;65. iii11-24.
5. Woo PC, Lau SK, Teng JL, Tse H, Yuen KY. Then and now: use of 16S rDNA gene
sequencing for bacterial identiﬁcation and discovery of novel bacteria in clinical
microbiology laboratories. Clin Microbiol Infect 2008;14:908–34.
